We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.
Canarypox virus (CNPV), an avipoxvirus, is the causative agent of canarypox, a disease of wild and captive birds that can cause significant damage. Canarypox virus is a member of the Poxviridae family. There are other nine well-known species in the poxviridae family, including: fowlpox virus, Juncopox virus, Mynahpox virus, Psittacinepox virus, Sparrowpox virus, Starlingpox virus, Pigeonpox virus, Turkeypox virus, and Quailpox virus.
CNPV is an infectious disease. CNPV can induce cellular, humoral and mucosal immune responses in the host after infection, and can be developed into a candidate vaccine vector after transformation, which can express various proteins of viruses and parasites. Therefore, the development of recombinant CNPV vector vaccine for immune prevention has the advantages of significant economic significance.
Figure 1. The canarypox vector (ALVAC) is a live attenuated virus with a large capacity to incorporate foreign genes.1
All of the birds showed thickened eye lid and scablike lesions on skin or feet.
Figure 2. Scab-like lesions on skin (a) and feet (b) (left). Thickened eye lids of affected birds (right).2
Creative Biolabs is committed to provide high-quality reagents and one-stop technical services for canarypox virus researchers worldwide. Please feel free to contact us.
References
We DO NOT PROVIDE ANY PRODUCTS OR SERVICES DIRECTLY TO PATIENTS. All of our products are for Research Use Only (RUO), NOT intended for diagnostic, therapeutic, or clinical use.